HCM - CIK 0001648257
The table below shows HUTCHMED (China) Ltd's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2019 | Q1 2018 |
|---|---|---|
| Revenue | $52.17M | $52.34M |
| Cost of revenue | - | - |
| Gross profit | - | - |
| R&D | $33.28M | $28.66M |
| SG&A | $10.20M | $7.02M |
| Operating income | -$36.05M | -$25.02M |
| Income tax | $1.31M | $1.56M |
| Net income | -$19.89M | -$11.73M |
| EPS (diluted) | - | - |
HUTCHMED (China) Ltd reported annual revenue of $548.51M for fiscal year 2025. That is down 13.0% from $630.20M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $216.08M (FY 2016) to $548.51M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.